Bulgaria Metodija Chadikovski, general manager at Roche Bulgaria, explains the importance of conducting high quality diagnostics to successfully target the right drug to the right patient as well as the affiliate’s commitment to developing the solutions that Bulgarian patients will need next. Could you please introduce yourself as well as your…
Hong Kong Johnny Tse, general manager of Roche Diagnostics Hong Kong, talks about the past seven years managing the affiliate, how the company became a market leader, and his aim to position Roche Diagnostic as a solutions provider. Having managed Roche Diagnostics Hong Kong for nearly seven years now, what have been…
Singapore As a strong advocate for APAC, Roche Diagnostics’ Managing Director for Asia Pacific, Lance Little, shares his insights on the nuances of the markets in the region, the value proposition of the company to its clients, the importance of testing for 60 percent of the world’s population as well as…
Hong Kong Andy Barnett, general manager (Hong Kong and Macau) for Roche, discusses the highlights of his past two years managing a local affiliate instead of heading a global business line, the key factors behind Roche’s top-5 positioning in the local market, and the huge potential for innovation in aspects like digital…
Colombia Spearheading the Colombian affiliate of the global leader in oncology, Carlos Estrada, General Manager of Roche Colombia shares his insights on the profound transformations of the Colombian healthcare system. He speaks about achieving optimal equilibrium in the system, the exciting pipeline ahead for Roche, as well as their strategies to…
Greece After an extensive career in pharma spanning multiple geographies, Roche’s Managing Director for Greece, Anne Nijs, is now tackling the Herculean challenge of the Greek pharmaceutical landscape. She speaks about Roche’s focus on bringing differentiated innovation to market, the holistic approach of the organization amidst the crisis, as well as…
Philippines Theresa Martinez, General Manager of Roche in the Philippines, defines the pillars of her five-year plan as twofold: lead broader and sustainable access to Roche medical innovations in the Philippines and create a great place to work. She elaborates on her goal of having an impact on the local healthcare…
Ireland Donal Higgins, MD of Prochem Engineering, provides an overview of their life sciences operations, the key innovations they are bringing to the industry like computational fluid dynamics (CFD), and his mission to position Prochem as the leading multi-disciplinary engineering company in the southeast of Ireland. Donal, can you give our…
Switzerland It is tempting to characterize Switzerland’s global pharma and life science hotspots as beginning and ending with Basel – home of industry giants Roche and Novartis. However, Zurich, Geneva, and even tiny Zug are all now staking serious claims for global recognition in this area. “Zurich is the world’s smallest…
Slovakia Dr. Natasa Klicko, General Manager of Roche Slovakia, outlines the challenges and opportunities for the company in the country; their strategy of going “beyond the pill” to partner with and provide value to all healthcare stakeholders; the importance of data and methodology in the debate on market access; and Slovakia…
Switzerland As the home market, Switzerland and Roche’s Swiss pharma operations play an important and pioneering role within Roche’s global organization, with early patient access to innovation and new commercial models taking place in the country. The working title of the Healthcare & Life Science Review Switzerland is “A Leader Among…
Pharma Thierry Guillot, president of Chugai Pharma France, talks about the challenge of transitioning from a small organization, which revolved around one main product into a larger entity capable of delivering multiple products and solutions; he also reveals how since 2008, Chugai and Roche have worked together on marketing and business…
See our Cookie Privacy Policy Here